Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is J.B. Chemicals & Pharmaceuticals Days Payable?
J.B. Chemicals & PharmaceuticalsBOM:506943 85 Days Payable is 130.09 as of Mar. 2026, which is 54% above its 10-year median of 84.33. GuruFocus rates BOM:506943 with a GF Score™ of 85/100 and a GF Value™ of ₹1,950.89 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 926 Drug Manufacturers companies, J.B. Chemicals & Pharmaceuticals ranks better than 63.5% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
J.B. Chemicals & Pharmaceuticals Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, J.B. Chemicals & Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
J.B. Chemicals & Pharmaceuticals Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, J.B. Chemicals & Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where J.B. Chemicals & Pharmaceuticals's Days Payable falls into.
J.B. Chemicals & Pharmaceuticals Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
J.B. Chemicals & Pharmaceuticals (BOM:506943) has a Days Payable of 130.09 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on J.B. Chemicals & Pharmaceuticals and its competitors. This is 54% above median its historical median of 84.33. Over the past decade, J.B. Chemicals & Pharmaceuticals' Days Payable has ranged from 62.72 to 113.70. According to the industry distribution chart, J.B. Chemicals & Pharmaceuticals ranks #338 out of 926 companies in the Drug Manufacturers industry, placing it in the top 36.5%.
Is J.B. Chemicals & Pharmaceuticals' Days Payable too high?
J.B. Chemicals & Pharmaceuticals' current Days Payable of 130.09 is 54% above median its 10-year median of 84.33. Over the past 10 years, this metric has ranged from a low of 62.72 to a high of 113.70. The Drug Manufacturers industry median Days Payable is 90.22. J.B. Chemicals & Pharmaceuticals' value of 130.09 is 44.2% above this industry median. Based on the distribution chart, J.B. Chemicals & Pharmaceuticals ranks #338 out of 926 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, J.B. Chemicals & Pharmaceuticals has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does J.B. Chemicals & Pharmaceuticals' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, J.B. Chemicals & Pharmaceuticals ranks #338 out of 926 companies for Days Payable. This puts J.B. Chemicals & Pharmaceuticals in the upper half of its industry. The industry median Days Payable is 90.22. J.B. Chemicals & Pharmaceuticals' value of 130.09 is 44.2% above this benchmark. Historically, J.B. Chemicals & Pharmaceuticals' own Days Payable has ranged from 62.72 to 113.70 over the past decade. While the company's 10-year median is 84.33 vs. the industry median of 90.22, J.B. Chemicals & Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. J.B. Chemicals & Pharmaceuticals's current Days Payable of 130.09 is 44.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on J.B. Chemicals & Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. J.B. Chemicals & Pharmaceuticals's current Days Payable is 130.09, which is 54% above median its own 10-year median of 84.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J.B. Chemicals & Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, J.B. Chemicals & Pharmaceuticals (BOM:506943) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,950.89, compared to a current price of ₹2,412.25 — trading 23.6% above its estimated fair value. The current Days Payable is 130.09, which is 54% above median its 10-year median of 84.33 and 44.2% above the Drug Manufacturers industry median of 90.22. J.B. Chemicals & Pharmaceuticals' overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For J.B. Chemicals & Pharmaceuticals (BOM:506943), the current Days Payable is 130.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is J.B. Chemicals & Pharmaceuticals (BOM:506943) Overvalued in 2026?
Based on GuruFocus' analysis, J.B. Chemicals & Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹2,412.25 is trading 23.6% above its estimated GF Value™ of ₹1,950.89.
GuruFocus considers J.B. Chemicals & Pharmaceuticals to be Modestly Overvalued.
Key valuation signals for BOM:506943:
Days Payable: 130.09 (54% above median its 10-year median of 84.33)
GF Value™: ₹1,950.89 vs. price of ₹2,412.25 (23.6% above fair value)
Industry Position: 44.2% above the Drug Manufacturers median (#338 of 926)
No single metric tells the full story. See the BOM:506943 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
J.B. Chemicals & Pharmaceuticals Business Description
J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, capsules, lozenges, syrups and injectables. It has only one reportable business segment, i.e., Pharmaceuticals. The Company derives revenue from the manufacturing and marketing of pharmaceutical products. The company sells its products in India and also exports them to other international countries. The maximum revenue is generated from India.
85GF Score
Get the complete analysis for BOM:506943
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506943 has been successfully added to your 
